
Yayınlanma: 19 Mart 2021 12:53
Güncellenme: 5 Aralık 2025 16:35
The company also benefits from the fact that Medicare (US national health insurance) accepts any American with end-stage kidney disease who needs dialysis, regardless of age.
This provides some insurance coverage for every American. According to HealthCare appraisers, DaVita controls about 37 percent of this market.
However, this market share does not isolate the company from all threats. In states such as California, parliament has set limits on third-party reimbursement rates for dialysis clinics in the context of the bill.
Fortunately for DaVita, the courts have so far blocked this practice from taking effect. However, such initiatives can limit revenues, especially in large states such as California. In addition, holistic (holistic, alternative medicine) approaches can challenge the traditional dialysis treatments DaVita specializes in.
In addition, companies such as Somatus are trying to prevent the need for dialysis. While such advances are helping kidney patients, they threaten DaVita's revenue streams.
In addition, as the COVID-19 outbreak made its clinics more dangerous, DaVita had to make extra efforts to separate positive patients, rearrange them and provide dialysis services at home. Despite these difficulties, revenue grew by just over 1 percent, while net income fell roughly 3 percent.




